Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PRAMEF8 Activators

The class of PRAMEF8 activators is characterized by their indirect action through various biochemical and cellular pathways, which culminates in the modulation of PRAMEF8 activity. These activators work by interfacing with different cellular mechanisms that include signaling cascades, gene expression regulation, and epigenetic modifications. Chemicals like db-cAMP and Forskolin exert their influence by raising intracellular cAMP levels, which subsequently activates PKA. This kinase can phosphorylate transcription factors that enhance the transcription of PRAMEF8, thus serving as an indirect method of activation. Similarly, AMPK activators such as A-769662 trigger a signaling cascade that can recalibrate cellular energy homeostasis and, consequently, modulate transcriptional networks affecting PRAMEF8 expression.

Epigenetic modulators, such as 5-Azacytidine and Trichostatin A, alter the epigenetic landscape by DNA methylation and promoting histone acetylation, respectively, leading to a more transcriptionally active chromatin state. These changes can potentiate the expression of PRAMEF8 if its promoter regions are subject to epigenetic control. In parallel, compounds like Resveratrol, Retinoic acid, and β-Estradiol can activate specific nuclear receptors, leading to the direct or indirect transcriptional upregulation of PRAMEF8. Retinoic acid, for instance, impacts gene expression through its interaction with RARs and RXRs, which may influence PRAMEF8 expression. Hormonal pathways, too, are implicated, with β-Estradiol modifying gene expression profiles through estrogen receptors that could encompass the regulatory sequences of PRAMEF8. Furthermore, signaling intermediates such as Lithium chloride act through the inhibition of GSK-3, a key regulator of the Wnt signaling pathway, leading to transcriptional outcomes that could include the modulation of PRAMEF8. On the metabolic front, PPAR agonists like Rosiglitazone impact lipid metabolism and inflammation-related gene expression, which might indirectly enhance PRAMEF8 expression by shifting the metabolic state of the cell. Zoledronic acid's influence on immune cell activation also exemplifies how changes in the immune landscape can affect PRAMEF8 expression indirectly.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

db-cAMP is a cell-permeable cAMP analog that activates protein kinase A (PKA). PKA activation can result in the phosphorylation of transcription factors that govern the expression of PRAMEF8, thereby modulating its expression levels and functional activity within the cell.

A-769662

844499-71-4sc-203790
sc-203790A
sc-203790B
sc-203790C
sc-203790D
10 mg
50 mg
100 mg
500 mg
1 g
$184.00
$741.00
$1076.00
$3417.00
$5304.00
23
(2)

A-769662 is an activator of AMP-activated protein kinase (AMPK). Upon activation, AMPK can initiate a cascade of events leading to the alteration of transcriptional programs that could encompass the regulation of PRAMEF8 expression, resulting in its activity enhancement.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol is a polyphenolic compound that can activate sirtuin 1 (SIRT1). Activation of SIRT1 has been linked to changes in chromatin state and transcription factor activity, which may extend to genes such as PRAMEF8, culminating in its transcriptional upregulation.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid, a metabolite of vitamin A, binds to retinoic acid receptors (RARs) which heterodimerize with retinoid X receptors (RXRs). This complex can then act on retinoic acid response elements (RAREs) in gene promoters, potentially influencing the expression of PRAMEF8.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine is a DNA methyltransferase inhibitor that can lead to the demethylation of DNA and thus reactivation of silenced genes. By this mechanism, it could enable the transcription of PRAMEF8 if its promoter were subject to methylation-based silencing.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

TSA is an inhibitor of histone deacetylases (HDACs), leading to hyperacetylation of histones and a more open chromatin configuration. This can increase the transcription of various genes, potentially including PRAMEF8, thereby facilitating its activation.

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$63.00
$182.00
8
(1)

β-Estradiol functions as a ligand for estrogen receptors, which can modulate the transcription of a diverse set of genes. Through this receptor-mediated transcription regulation, it can affect the expression profile of PRAMEF8, leading to its activation.

Zoledronic acid, anhydrous

118072-93-8sc-364663
sc-364663A
25 mg
100 mg
$92.00
$256.00
5
(0)

Zoledronic acid is a bisphosphonate that can lead to the accumulation of isopentenyl pyrophosphate (IPP), a metabolite that can activate gamma-delta T cells. This activation could modulate immune responses that indirectly influence the expression of PRAMEF8 in immune-related pathways.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

PPAR agonists bind to PPAR receptors, leading to the modulation of genes involved in lipid metabolism and inflammation. Through such regulation, these agonists may indirectly affect the expression or function of PRAMEF8 by altering the cellular metabolic state.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin directly stimulates adenylate cyclase, thereby increasing levels of cAMP within cells. Elevated cAMP can activate PKA, which may phosphorylate transcription factors or other proteins that govern PRAMEF8's expression, leading to its upregulation.